Acumen Pharmaceuticals (ABOS) Other Accumulated Expenses (2020 - 2022)
Acumen Pharmaceuticals (ABOS) posted Other Accumulated Expenses of $37000.0 for Q3 2022, down 63.37% sequentially from $101000.0 in Q2 2022, and down 68.91% YoY from $119000.0 in Q3 2021.
Acumen Pharmaceuticals (ABOS) Other Accumulated Expenses (2020 - 2022) Analysis & Trends
Acumen Pharmaceuticals has reported Other Accumulated Expenses for 3 years, with the latest figure at $37000.0 in Q3 2022.
- Quarterly Other Accumulated Expenses fell 68.91% year-over-year to $37000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $37000.0 (down 68.91% YoY) and the FY2021 annual result came in at $204000.0, up 126.67% from the prior year.
- Other Accumulated Expenses retreated to $37000.0 in Q3 2022 per ABOS's latest filing, from $101000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $204000.0 in Q4 2021 and troughed at $37000.0 in Q3 2022.
- A 3-year average of $100285.7 and a median of $99000.0 in 2022 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses jumped 126.67% in 2021, then plunged 68.91% in 2022.
- Over 3 years, Other Accumulated Expenses stood at $90000.0 in 2020, then surged by 126.67% to $204000.0 in 2021, then plunged by 81.86% to $37000.0 in 2022.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $37000.0, $101000.0, and $99000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Acumen Pharmaceuticals | 226.87 Mn | 226.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 37,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 204,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Dec 31, 2020 | 90,000.00 |